Resultados de la búsqueda 531-540 of 19060 for Two-phase

  1. Oncología (médica) - Ensayos clínicos

    ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...

  2. Oncología (médica) - Ensayos clínicos

    ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... Stage IIA-IIIB NSCLC undergoing curative-intent resection. We will assess ... This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of ...

  4. Neurología - Ensayos clínicos

    The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...

  5. Oncología (médica) - Ensayos clínicos

    ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...

  6. Oncología (médica) - Ensayos clínicos

    ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...

  7. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

    MC1733, Phase I Trial of Intratumoral ... The purpose of this study is to assess outcomes, satisfaction and aesthetics of two ... Ir a página 22 · Ir a ...

  8. Oncología (médica) - Ensayos clínicos

    ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...

  9. Radiología - Ensayos clínicos - Mayo Clinic

    ADPKD is a leading cause of end-stage renal disease. ... A Study to Compare Two Ultrasound-based Methods for Assessing Diaphragm Muscle Function ... ADPKD is a ...

  10. Oncología (médica) - Ensayos clínicos

    This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric and ...